TScan Therapeutics Announces Publication of Study in Immunity Highlighting the Discovery of Novel T Cell Targets in COVID-19 October 21, 2020
Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies for the Treatment of COVID-19 October 21, 2020
TScan Announces Discovery of Precise T Cell Targets in COVID-19 Convalescent Patients to Inform Development of Next-generation Vaccines and T Cell-based Diagnostics July 28, 2020
COVID-19 Patients Form Memory CD8+ T Cells that Recognize a Small Set of Shared Immunodominant Epitopes in SARS-CoV-2 July 27, 2020
